on INNATE PHARMA (EPA:IPH)
Innate Pharma at the 43rd JP Morgan Healthcare Conference
Innate Pharma has announced that it will participate in the 43rd JP Morgan Healthcare Conference, which will be held in San Francisco from January 13-16, 2025. Jonathan Dickinson, Chairman of the Executive Board, will represent the company at a session scheduled for January 14. Other executives , including Dr. Sonia Quaratino and Yannis Morel, will also participate.
The event will be accessible online via the Innate Pharma website. This conference is an opportunity for Innate to present its current projects, particularly in the field of cancer immunotherapy. Innate is listed on Euronext Paris and Nasdaq .
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all INNATE PHARMA news